T1	Participants 119 209	131 patients with stage II-III-IV squamous cell carcinoma of the oropharynx or oral cavity
T2	Participants 704 740	total of 116 patients were evaluable
T3	Participants 742 857	Of 55 patients in the chemotherapy arm, four (7%) had a complete response (CR) and 23 (42%) a partial response (PR)
T4	Participants 936 1047	76% (42 of 55) of patients in the experimental group were in CR compared to 89% (54 of 61) in the control group
T5	Participants 1432 1443	35 patients
